Table 3: GRADE Quality Assessment for CSII pumps vs. MDI on HbA1c Adults with Type 2 Diabetes.

Study	Design	Study Quality	Consistency	Directness	Other modifying factors	Overall quality of evidence
Raskin 2003	RCT	Serious limitations* MODERATE	Consistent LOW	Indirect† LOW
Herman 2005	RCT HIGH				Not applicable	LOW

^*Inadequate or unknown allocation concealment (all studies); Unblinded assessment (all studies) however lack of blinding due to the nature of the study; ITT not well explained in 1 of 2 studies

^†Indirect due to lack of generalizability of findings since participants varied with respect to prior treatment regimens and intensive SMBG suggests highly motivated populations used in trials.